Peter M Glazer

28PUBLICATIONS
113CO-AUTHORS
Molecular targetsMedical devicesPredictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Dec 08, 2025
PARP inhibitor resistance in IDH1-mutant cancers due to loss of end protection factors, 53BP1 and REV7.

Daniel Andrés Colón-Ríos, Jonathan Dow, Adam Krysztofiak

|Sep 12, 2025
Hypoxia Induces Immunosuppression by Silencing STING in Cancer.

Yuhong Lu, Annali M Yurkevicz, Yanfeng Liu

|Jul 16, 2025
Systemic administration of an RNA binding and cell-penetrating antibody targets therapeutic RNA to multiple mouse models of cancer.

Elias Quijano, Diana Martinez-Saucedo, Zaira Ianniello

|Jun 10, 2025
Systemic in utero gene editing as a treatment for cystic fibrosis.

Adele S Ricciardi, Christina Barone, Rachael Putman

|Oct 09, 2024
Tumor-Specific Antigen Delivery for T-cell Therapy via a pH-Sensitive Peptide Conjugate.

Annali M Yurkevicz, Yanfeng Liu, Samuel G Katz

|Sep 16, 2024
Systemic in utero gene editing as a treatment for cystic fibrosis.

Adele S Ricciardi, Christina Barone, Rachael Putman

Pageof 5